LA
MANE

Lee Ainslie’s Veradermics Inc MANE Stock Holding History

Lee Ainslie’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.1M Buy
+789,980
New +$74M 0.86% 37

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Lee Ainslie's MANE Position: Q2 2026 in Review

Lee Ainslie opened a new position in Veradermics Inc (MANE) in Q2 2026: 789,980 shares worth $97.1M. The stake represents 0.86% of the portfolio and ranks #37 among its holdings.

163 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Lee Ainslie held 789,980 shares of Veradermics Inc worth $97.1M as of Q2 2026.
  • Veradermics Inc was a new Lee Ainslie position in Q2 2026.
  • Veradermics Inc made up 0.86% of Lee Ainslie's portfolio in Q2 2026, its #37 holding.
  • 163 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.